Microbial metabolites are also emerging as useful biomarkers and clinical tools to evaluate disease predisposition and progression, and further research will hopefully define new uses of microbial metabolites for not only the treatment of metabolic disease but also its prevention
In summary, nanomedicine and CRISPR gene editing technology are expected to hugely facilitate the treatment effect of periodontitis through precision therapy and gene repair, and become an vital tool for personalized treatment
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors a novel mechanism not shared by currently licensed treatments such as semaglutide or tirzepatide
Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM (2004) Regulation of muscle fiber type and running endurance by PPARdelta